Acute myeloid leukaemia with NPM1 mutation: no longer having an absolute blast (count)

Lucy Zhang; Victoria Campion; Michelle Dickson; Catherine Tang

doi:10.1016/j.pathol.2022.10.009

Acute myeloid leukaemia with NPM1 mutation: no longer having an absolute blast (count)

Lucy Zhang
, Victoria Campion
, Michelle Dickson
, Catherine Tang

Research output: Contribution to journal › Article › peer-review

3 Citations (Scopus)

Abstract

Increasing recognition of diagnostic and prognostic implications of molecular abnormalities in acute myeloid leukaemia (AML) have led to the incorporation of entities with disease-defining mutations in recent revisions of the
World Health Organization (WHO) classification of haematolymphoid tumours.

Original language	English
Pages (from-to)	578-581
Number of pages	4
Journal	Pathology
Volume	55
Issue number	4
DOIs	https://doi.org/10.1016/j.pathol.2022.10.009
Publication status	Published - Jun 2023
Externally published	Yes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.1016/j.pathol.2022.10.009

Cite this

@article{0e9927a824864722b803fe1397c6c00f,

title = "Acute myeloid leukaemia with NPM1 mutation: no longer having an absolute blast (count)",

abstract = "Increasing recognition of diagnostic and prognostic implications of molecular abnormalities in acute myeloid leukaemia (AML) have led to the incorporation of entities with disease-defining mutations in recent revisions of the World Health Organization (WHO) classification of haematolymphoid tumours.",

author = "Lucy Zhang and Victoria Campion and Michelle Dickson and Catherine Tang",

year = "2023",

month = jun,

doi = "10.1016/j.pathol.2022.10.009",

language = "English",

volume = "55",

pages = "578--581",

journal = "Pathology",

issn = "0031-3025",

publisher = "Elsevier B.V.",

number = "4",

}

TY - JOUR

T1 - Acute myeloid leukaemia with NPM1 mutation

T2 - no longer having an absolute blast (count)

AU - Zhang, Lucy

AU - Campion, Victoria

AU - Dickson, Michelle

AU - Tang, Catherine

PY - 2023/6

Y1 - 2023/6

N2 - Increasing recognition of diagnostic and prognostic implications of molecular abnormalities in acute myeloid leukaemia (AML) have led to the incorporation of entities with disease-defining mutations in recent revisions of the World Health Organization (WHO) classification of haematolymphoid tumours.

AB - Increasing recognition of diagnostic and prognostic implications of molecular abnormalities in acute myeloid leukaemia (AML) have led to the incorporation of entities with disease-defining mutations in recent revisions of the World Health Organization (WHO) classification of haematolymphoid tumours.

UR - https://www.scopus.com/pages/publications/85156237211

UR - https://go.openathens.net/redirector/westernsydney.edu.au?url=https://doi.org/10.1016/j.pathol.2022.10.009

U2 - 10.1016/j.pathol.2022.10.009

DO - 10.1016/j.pathol.2022.10.009

M3 - Article

C2 - 36707319

AN - SCOPUS:85156237211

SN - 0031-3025

VL - 55

SP - 578

EP - 581

JO - Pathology

JF - Pathology

IS - 4

ER -

Acute myeloid leukaemia with NPM1 mutation: no longer having an absolute blast (count)

Abstract

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this